Home / Publication / A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

論文

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

Author(s): Laetitia Canini, Annabelle Lemenuel-Diot, Barbara J. Brennan, Patrick F. Smith, Alan S. Perelson

Year: 2017年1月10日

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

ウェビナー

トランスレーショナル開発における中和ADA効果の薬物動態モデリング

オンデマンド・ウェビナー

Extrapolating AUC to Infinity

ブログ

Powered by Translations.com GlobalLink Web Software

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

A Pharmacokinetic/Viral Kinetic Model to Evaluate Treatment of Chronic HCV Infection with a Non-nucleoside Polymerase Inhibitor

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

トランスレーショナル開発における中和ADA効果の薬物動態モデリング

Extrapolating AUC to Infinity

メルマガ登録

クイックアクセス

ソリューション

お問合せ